Literature DB >> 23336472

Menopausal symptoms in breast cancer survivors: management update.

Leila Cusack1, Meagan Brennan, Rodney Baber, Frances Boyle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23336472      PMCID： PMC3529282          DOI： 10.3399/bjgp13X660977

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  14 in total

Review 1.  Alternative and complementary therapies for the menopause.

Authors:  Francesca Borrelli; Edzard Ernst
Journal:  Maturitas       Date:  2010-06-30       Impact factor: 4.342

Review 2.  Management of menopausal symptoms in breast cancer patients.

Authors:  S Loibl; A Lintermans; A S Dieudonné; P Neven
Journal:  Maturitas       Date:  2010-12-23       Impact factor: 4.342

3.  Menopausal hormone therapy after breast cancer: the Stockholm randomized trial.

Authors:  Eva von Schoultz; Lars E Rutqvist
Journal:  J Natl Cancer Inst       Date:  2005-04-06       Impact factor: 13.506

Review 4.  Management of menopausal symptoms in patients with breast cancer: an evidence-based approach.

Authors:  Martha Hickey; Christobel M Saunders; Bronwyn G A Stuckey
Journal:  Lancet Oncol       Date:  2005-09       Impact factor: 41.316

5.  Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study.

Authors:  Marilyn L Kwan; Lawrence H Kushi; Erin Weltzien; Emily K Tam; Adrienne Castillo; Carol Sweeney; Bette J Caan
Journal:  J Clin Oncol       Date:  2010-08-30       Impact factor: 44.544

6.  Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.

Authors:  Lesley Fallowfield; David Cella; Jack Cuzick; Stephen Francis; Gershon Locker; Anthony Howell
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

Review 7.  Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.

Authors:  David Cella; Lesley J Fallowfield
Journal:  Breast Cancer Res Treat       Date:  2007-09-18       Impact factor: 4.872

Review 8.  Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer.

Authors:  M Hickey; C Saunders; A Partridge; N Santoro; H Joffe; V Stearns
Journal:  Ann Oncol       Date:  2008-06-02       Impact factor: 32.976

9.  HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.

Authors:  L Holmberg; H Anderson
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

10.  Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial.

Authors:  Eleanor Mann; Melanie J Smith; Jennifer Hellier; Janet A Balabanovic; Hisham Hamed; Elizabeth A Grunfeld; Myra S Hunter
Journal:  Lancet Oncol       Date:  2012-02-15       Impact factor: 41.316
View more
  8 in total

Review 1.  A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy.

Authors:  Mariana S Sousa; Michelle Peate; Sherin Jarvis; Martha Hickey; Michael Friedlander
Journal:  Ther Adv Med Oncol       Date:  2017-01-31       Impact factor: 8.168

2.  The Management of Menopausal Symptoms in Women Following Breast Cancer: An Overview.

Authors:  Cheryl Phua; Rodney Baber
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

3.  Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors.

Authors:  Sarah J O Nomura; Yi-Ting Hwang; Scarlett Lin Gomez; Teresa T Fung; Shu-Lan Yeh; Chiranjeev Dash; Laura Allen; Serena Philips; Leena Hilakivi-Clarke; Yun-Ling Zheng; Judy Huei-Yu Wang
Journal:  Breast Cancer Res Treat       Date:  2017-12-11       Impact factor: 4.624

4.  Analysis and Identification of Active Compounds from Gami-Soyosan Toxic to MCF-7 Human Breast Adenocarcinoma Cells.

Authors:  Mi-Yeon Jung; Chang-Seob Seo; Seon-Eun Baek; Jaemin Lee; Myoung-Sook Shin; Ki Sung Kang; Sullim Lee; Jeong-Eun Yoo
Journal:  Biomolecules       Date:  2019-07-10

5.  Symptomatic menopausal transition and risk of subsequent stroke.

Authors:  Chao-Hung Yu; Chew-Teng Kor; Shuo-Chun Weng; Chia-Chu Chang; Ching-Pei Chen; Chia-Lin Wu
Journal:  PeerJ       Date:  2019-10-30       Impact factor: 2.984

Review 6.  Management of genitourinary syndrome of menopause in breast cancer survivors: An update.

Authors:  Daniel María Lubián López
Journal:  World J Clin Oncol       Date:  2022-02-24

7.  Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer.

Authors:  Beomyoung Cho; Maria Pérez; Donna B Jeffe; Matthew W Kreuter; Julie A Margenthaler; Graham A Colditz; Ying Liu
Journal:  BMC Cancer       Date:  2022-08-01       Impact factor: 4.638

Review 8.  Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies.

Authors:  Smarakan Sneha; Simon C Baker; Andrew Green; Sarah Storr; Radhika Aiyappa; Stewart Martin; Klaus Pors
Journal:  Biomedicines       Date:  2021-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.